Continuation rates and reasons for discontinuing TCu380A IUD use in Tabriz, Iran

Contraception

Volumn 74, Issue 6, 2006, Pages 483-486

  Jenabi, Encieh ^a   Alizade, Sakine Mohammad ^b   Baga, Reyhane Ivan ^b  

^a Department of Midwifery   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Continuation rate; Discontinuation reasons; Intrauterine device; TCu380A IUD

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; IRAN; NORMAL HUMAN; PAIN; PREGNANCY RATE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; DATA COLLECTION; FEMALE; HUMANS; INTRAUTERINE DEVICES, COPPER; IRAN; RANDOM ALLOCATION; TIME FACTORS;

EID: 33845945176     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.08.007     Document Type: Article

References (13)

1. Thonneau P., Goulard H., and Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 64 (2001) 33-37
2. Mishell D.R. Intrauterine devices: mechanisms of action, safety and efficacy. Contraception 58 (1998) S45-S53
3. Ministry of Health and Medical Education-Bureau of Population and Family Health, Population and Health in the Islamic Republic of Iran-DHS, October 2000 Tehran: the Ministry of Health and Medical education and the United Nations Children's Fund (UNICEF); 2000. p. 64.
4. Salazar-Martinez E., Lazcano-Ponce E.C., Gonzalez Lira-Lira G., Escudero-De los Rios P., Salmeron-Castro J., and Hernandez-Avila M. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res 59 (1999) 3658-3662
5. Sivin I. Should collared CuT intrauterine devices be replaced before eight years?. Br J Fam Plann 18 (1992) 9-11
6. Efficacy and failure rate of IUD. Management of common genital infections. IPPF Med Bull 28 5 (1994) 4
7. Rivera R., and Best K. Current opinion consensus statement on intrauterine contraception. Contraception 65 (2002) 385-388
8. Reinprayoon D., Gilmore C., Farr G., and Amatya R. Twelve-month comparative multicenter study of the TCU 380A and ML 250 intrauterine devices in Bangkok, Thailand. Contraception 58 (1998) 201-206
9. Meirik O., Farley M.M., Sivin I., and Diaz S. Post-marketing surveillance of Norplant contraceptive implants: contraceptive efficacy and reproductive health. Contraception 63 (2001) 167-186
10. Rosenberg M.J., Foldesy R., Mishell D.R., Speroff L., Waugh M.S., and Burkman R. Performance of the TCU 380 A and Cu-Fix IUDs in an international randomized trial. Contraception 53 (1996) 197-203
11. Trieman K., Liskin L., Kols A., and Rinehart W. IUD: an update. Population reports, Series B, No. 6 (1995), Johns Hopkins University, Baltimore
12. Bonacho I., Pita S., Inmaculada M., and Besteiro G. Eight years with the same IUD. Contraception 59 (1999) 233-236
13. Mohammad Alizadeh S., Baradaran Rezaie M., and Rangi A. Depot-medroxyprogesterone acetate: patterns of use and reasons for discontinuation. Fourth international Research Conference, Japan Academy of Nurses Science (2001)